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that of traditional glucocorticosteroides for prevention of disease
progression of Collagen-Induced Arthritis (CIA) in rats and to
compare biochemical markers of cartilage degradation systemi-
cally in serum and locally in joint extracts to the degree of joint
erosion, paw swelling and joint score.
Methods: Fifty female Lewis rats (150-175g) were randomized
into 5 groups, and arthritis was induced in 4 groups by intrader-
mal injection of porcine type II collagen at the base of the tail on
day 0 and 7. One group was treated with 17-β-estradiol (0.18mg
pellet/60 days release) and two groups with a low or high dose of
oral prednisolone (0.6mg/kg/day or 3mg/kg/day). Disease onset
was registered as the first sign of swelling and redness of one
hind paw. Hind paw score (0-4, 4=most severe) and hind paw
volume was measured from day 8 after immunization. Urine and
serum was collected at baseline and 7, 14 and 21 days after
immunization. One hind paw was snap-frozen in liquid nitrogen,
homogenized and extracted for proteins, while the other hind
paw was fixated in formaldehyde and decalcified in EDTA for
histology and immunohistochemistry.
Levels of C-terminal telopeptides of type II collagen (CTX-II), C-
terminal telopeptides of type I collagen (CTX-I), tartrate-resistant
acid phosphatase (TRAP) and N-terminal propeptide of type
II collagen (PIINP) were measured in serum and in protein
extracts from control and diseased paws. Cartilage condition
was assessed by proteoglycan loss, osteophyte formation and
cartilage erosion in the tibiotarsal joint. Immunohistochemistry
was performed for the CTX-II epitope.
Results: In collagen injected non-treated animals, disease in-
cidence occurred from day 11 after the first collagen injection
and increased rapidly to 100% on day 15 (figure A). Estrogen
treatment both delayed disease onset and reduced disease oc-
currence by 43%. Both the high and low dose of prednisolone
efficiently prevented disease onset and progression (paw score
and paw volume). Compared to the control, the delta paw volume
on day 21 was significantly increased by 650% (p<0.001) in the
non-treated collagen-injected group, while estrogen treatment
significantly decreased this volume by 54% (p<0.01). These
changes in paw volume were accompanied in the serum by a
223% increase (P<0.001) in CTX-II levels from control to CIA-
group, and a 43% reduction from CIA-group to estrogen-group
(see figure B), indicating a correlation between paw volume as a
measure of disease pathology and serum CTX-II. In alignment,
prednisolone treatment resulted in a complete repression of CTX-
II values to control levels (p<0.001). Local joint pathology was
evaluated in paw extracts. CIA resulted in a 2000% increased
CTX-II level (P<0.01), which was significantly inhibited by both
estrogen and prednisolone. Immunohistochemistry showed that
CTX-II was localized to the eroded surface of articular cartilage.
Conclusions: Disease onset was associated with a marked
day-to-day increase in paw volume and paw score. Estrogen
Fig. A. Disease incidence in rats.
Fig. B. Serum CTX-II in rats – day 21.
significantly decreased disease incidence and progression, and
significantly haltered cartilage degradation evaluated by cartilage
degradation products, both locally and systemically. We suggest
that in addition to traditional methods used to access disease
progression, cartilage degradation products, which both can be
measured pre-clinically and clinically, can provide additional and
important information.
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Purpose: Chondrocyte apoptosis has been suggested to play
an important role in the pathogenesis of osteoarthritis (OA).
Numerous studies have reported a linear relationship between
apoptosis of articular chondrocytes and the degree of cartilage
degradation. However, it remains unclear whether chondrocyte
apoptosis is a cause of, or the result of, cartilage matrix break-
down. The aim of this study was to investigate the relationship
between early articular cartilage (AC) degeneration and chon-
drocyte apoptosis.
Methods: The study comprised AC taken from the left and right,
metacarpophalangeal (MCP) and metatarsophalangeal (MTP)
joints of 8 horses obtained from the local abattoir. The joints
were opened and the cartilage visually graded using a macro-
scopic OA grading system. Full depth AC was removed from six
specific sites across each joint; scores from each of these sites
were pooled in any analysis performed. For each horse, AC from
each of the 4 joints and from each sampling site was not always
available; this gave a total number of 149 cartilage specimens.
7μm cryostat sections were obtained. Haematoxylin and Eosin
with Safranin-O stained sections were used to score structural
differences between samples for features of cartilage pathol-
ogy using a ’modified’ Mankin scoring system. Apoptotic chon-
drocytes were identified using an indirect immunohistochemical
staining technique to detect the expression of active caspase-3
using a commercially available polyclonal antibody.
Results: Kruskal-Wallis with Dunn’s post test illustrated signifi-
cant differences in overall apoptosis when cartilage specimens
with a ‘modified’ Mankin score of 3 were compared to grade 2
(p<0.001**), grade 1 (p<0.001**) and grade 0 (p<0.05*) carti-
lage specimens. However no significant (ns) difference in overall
apoptosis was noted between grade 3 and grade 4 and 5 speci-
mens (Figure). The rate of apoptosis appears to increase linearly
from grade 0 to 3, but unchanged from grade 3-5. Similar findings
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were obtained when each zone of AC was analysed separately
and also when data for MCP and MTP joints was analysed
individually.
Conclusions: The apparent linear increase in chondrocyte apop-
tosis at early stages of AC degradation (‘modified’ Mankin grades
0-3) suggests that this process may play a significant role in the
initiation of cartilage damage. This data therefore supports the
notion that cell death by apoptosis may be an important ae-
tiopathogenic mechanism in OA.
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Purpose: The importance of nitric oxide (•NO) as a key mediator
in the pathophysiology of osteoarthritis (OA) has been well docu-
mented. The underlying mechanism involves the induction of •NO
and prostaglandin E2 (PGE2) by pro-inflammatory cytokines, that
lead to the degradation of the extracellular matrix constituents.
Fibronectin is a component of the extracellular matrix. In OA,
fibronectin is degraded into small fragments and these degra-
dation products could play a major role in cartilage breakdown.
Recent studies have shown that fibronectin fragments (Fn-F)
enhance the release of •NO and/or matrix metalloproteinase
(MMP) enzymes. However, these studies focused primarily on
the pathways in the absence of mechanical stimuli. We have pre-
viously shown that dynamic compression counteracts •NO and
PGE2 release in the presence of IL-1β. The current study exam-
ines the biochemical changes observed by chondrocyte/agarose
constructs subjected to dynamic compression in the presence of
Fn-F.
Methods: Initial dose response studies were conducted under
free-swelling conditions in order to determine the appropriate
concentration of Fn-F for the mechanical loading studies. Chon-
drocyte/agarose constructs were cultured for 48 hours in radio-
labelled media containing 0, 0.01, 0.1, 1 or 10 μg ml-1 of the
heparin binding 40 kDa Fn-F, +/- 1 mM L-NIO (NOS inhibitor).
For the mechanical loading studies, constructs were subjected
to 15% dynamic compressive strain at 1 Hz frequency for 48
hours in media supplemented with 0 or 10 μg ml-1 Fn-F, +/- 1
mM 1400 W (iNOS inhibitor). Nitrite and PGE2 release, [3H]-
thymidine and 35SO4 incorporation were measured using well
established biochemical assays.
Results: Fn-F at concentrations of 0.1, 1 and 10 μg ml-1 in-
creased nitrite release when compared to control constructs (all
p<0.001). L-NIO downregulated nitrite release when constructs
were cultured with 10 μg.ml-1Fn-F (p<0.05). By contrast, Fn-F
did not significantly influence PGE2 release in the presence and
absence of L-NIO. [3H]-thymidine incorporation was downregu-
lated with 1 and 10 μg.ml-1 Fn-F when compared to control con-
structs (p<0.05 and p<0.001). 10 μg.ml-1 Fn-F inhibited 35SO4
incorporation when compared to control construct (p.0.001) and
this response was reversed by L-NIO (p<0.01).
In unstrained constructs, 10 μg.ml-1 Fn-F upregulated nitrite re-
lease when compared to control constructs (p<0.001). Dynamic
compression inhibited nitrite release in the absence and pres-
ence of Fn-F (both p<0.001) and this effect was abolished with
1400 W. Dynamic compression in the presence and absence of
Fn-F did not significantly influence PGE2 release (Fig. 2B). In
unstrained constructs, Fn-F and 1400 W increased PGE2 release
when compared to control constructs (p<0.01). This effect was
not influenced by dynamic compression. In the absence of Fn-F,
dynamic compression upregulated [3H]-thymidine (p<0.001) and
35SO4 incorporation (p<0.01). The upregulation of [3H]-thymidine
and 35SO4 incorporation by dynamic compression was abolished
with Fn-F and enhanced with 1400 W (p<0.001 and p<0.01,
respectively).
Conclusions: The current study demonstrates that Fn-F stim-
ulates •NO release and this effect could be abolished by me-
chanical load. PGE2 levels were not influenced by the presence
of Fn-F, suggesting alternative pathways which could activate
IL-1β and/or MMP expression. Thus, a suppression of •NO is
important in mediating the upregulation of cell proliferation and
proteoglycan synthesis in response to dynamic compression.
Further characterization of the mechanotransduction pathway in
the presence of inflammatory mediators may identify pharmaco-
logical targets for the treatment of OA.
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Purpose: Interleukin-1β (IL-1β) stimulated chondrocytes produce
a variety of mediators of cartilage degradation including matrix
metalloproteinases (MMPs) that play a pivotal role in joint de-
struction in osteoarthritis (OA). The objective of this study was to
characterize the high molecular weight (HMW) MMPs produced
by IL-1β-stimulated OA chondrocytes that are also found in the
synovial fluid of OA joints.
Methods: Chondrocytes were prepared by enzymatic digestion
of OA cartilage. Nearly confluent chondrocyte cultures were
serum-starved overnight and stimulated with IL-1β for different
time periods. Substrate-embedded enzymography and collagen
degradation assays were used to characterize the MMP activity
in chondrocyte conditioned media and also in OA synovial fluid.
Western immunoblotting and immunoprecipitation was used to
confirm the presence of specific MMP proteins. Chondrocyte
nucleofection with small interfering RNAs (siRNAs) was used
to knockdown MMP-9, MMP-13 and NGAL gene expression.
Quantitative RT-PCR was employed to quantify MMP and NGAL
mRNA expression. Cartilage explants were stained with Safranin-
O/Fast Green and proteoglycan and collagen degradation was
determined in the cell culture supernatant with metachromatic
dye assays.
Results: One of the HMW MMPs of ∼130-kDa found in OA
synovial fluid was a complex of MMP-9 and NGAL. Immunologi-
cal, biochemical and molecular biology approaches were used to
confirm this result. Western immunoblotting showed that OA syn-
ovial fluid contained high levels of NGAL, MMP-9, and MMP-13
